Yerramilli U - Search Results

1

Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator.

Surapaneni S, Yerramilli U, Bai A, Dalvie D, Brooks J, Wang X, Selkirk JV, Yan YG, Zhang P, Hargreaves R, Kumar G, Palmisano M, Tran JQ. Surapaneni S, et al. Among authors: yerramilli u. Drug Metab Dispos. 2021 May;49(5):405-419. doi: 10.1124/dmd.120.000220. Epub 2021 Mar 4. Drug Metab Dispos. 2021. PMID: 33674268 Clinical Trial.

2

Absorption, distribution, metabolism, and excretion of mTOR kinase inhibitor CC-223 in rats, dogs, and humans.

Tong Z, Atsriku C, Yerramilli U, Wang X, Nissel J, Li Y, Surapaneni S. Tong Z, et al. Among authors: yerramilli u. Xenobiotica. 2019 Jan;49(1):43-53. doi: 10.1080/00498254.2017.1413718. Epub 2017 Dec 19. Xenobiotica. 2019. PMID: 29206565

3

Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans.

Tong Z, Atsriku C, Yerramilli U, Wang X, Li Y, Reyes J, Fan B, Yang H, Hoffmann M, Surapaneni S. Tong Z, et al. Among authors: yerramilli u. Xenobiotica. 2019 Feb;49(2):200-210. doi: 10.1080/00498254.2018.1425511. Epub 2018 Jan 22. Xenobiotica. 2019. PMID: 29320949

4

The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions.

Tong Z, Yerramilli U, Surapaneni S, Kumar G. Tong Z, et al. Among authors: yerramilli u. Cancer Chemother Pharmacol. 2014 Apr;73(4):869-74. doi: 10.1007/s00280-014-2415-y. Epub 2014 Mar 14. Cancer Chemother Pharmacol. 2014. PMID: 24627218

5

In vitro inhibition of human nucleoside transporters and uptake of azacitidine by an isocitrate dehydrogenase-2 inhibitor enasidenib and its metabolite AGI-16903.

Tong Z, Yerramilli U, Yao S, Young JD, Hoffmann M, Surapaneni S. Tong Z, et al. Among authors: yerramilli u. Xenobiotica. 2019 Oct;49(10):1229-1236. doi: 10.1080/00498254.2018.1539783. Epub 2018 Nov 29. Xenobiotica. 2019. PMID: 30394160

6

In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice.

Hu R, Shen G, Yerramilli UR, Lin W, Xu C, Nair S, Kong AN. Hu R, et al. Among authors: yerramilli ur. Arch Pharm Res. 2006 Oct;29(10):911-20. doi: 10.1007/BF02973914. Arch Pharm Res. 2006. PMID: 17121188

7

Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide.

Kadam Y, Yerramilli U, Bahadur A, Bahadur P. Kadam Y, et al. Among authors: yerramilli u. Colloids Surf B Biointerfaces. 2011 Mar;83(1):49-57. doi: 10.1016/j.colsurfb.2010.10.041. Epub 2010 Nov 2. Colloids Surf B Biointerfaces. 2011. PMID: 21123038

8

Solubilization of poorly water-soluble drug carbamezapine in pluronic micelles: effect of molecular characteristics, temperature and added salt on the solubilizing capacity.

Kadam Y, Yerramilli U, Bahadur A. Kadam Y, et al. Among authors: yerramilli u. Colloids Surf B Biointerfaces. 2009 Aug 1;72(1):141-7. doi: 10.1016/j.colsurfb.2009.03.027. Epub 2009 Apr 5. Colloids Surf B Biointerfaces. 2009. PMID: 19403275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters